Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil

• Published in: Memorias do Instituto Oswaldo Cruz
• Main Authors: Humberto Fabio Boatto, Sarah Desirée Barbosa Cavalcanti, Gilda MB Del Negro, Manoel João BC Girão, Elaine Cristina Francisco, Kelly Ishida, Olga Fischman Gompertz
• Format: Article
• Language: English
• Published: Fundação Oswaldo Cruz (FIOCRUZ) 2016-06-01
• Subjects: Candida duobushaemulonii; recurrent vulvovaginal candidiasis; antifungal susceptibility testing
• Online Access: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762016000600407&lng=en&tlng=en

The aim of this study was to identify Candida species isolated from women diagnosed with recurrent vulvovaginal candidiasis (RVVC) and their partners; and to evaluate the fluconazole (FLZ) susceptibility of the isolates. In a period of six years, among 172 patients diagnosed with vulvovaginal candidiasis, 13 women that presented RVVC and their partners were selected for this investigation. The isolates were obtained using Chromagar Candida medium, the species identification was performed by phenotypic and molecular methods and FLZ susceptibility was evaluated by E-test. Among 26 strains we identified 14 Candida albicans, six Candida duobushaemulonii, four Candida glabrata, and two Candida tropicalis. Agreement of the isolated species occurred in 100% of the couples. FLZ low susceptibility was observed for all isolates of C. duobushaemulonii (minimal inhibitory concentration values from 8-> 64 µg/mL), two C. glabrata isolates were FLZ-resistant and all C. albicans and C. tropicalis isolates were FLZ-susceptible. This report emphasises the importance of accurate identification of the fungal agents by a reliable molecular technique in RVVC episodes besides the lower antifungal susceptibility profile of this rare pathogen C. duobushaemulonii to FLZ.